COLUMBIA, Md., Jan. 8 Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the upcoming 11th Annual ICR XChange investor conference. The conference is being held January 14-15, 2009 at The St. Regis Monarch Beach Resort & Spa in Dana Point, California. Peter L. Buzy, Chief Financial Officer, and David Abramson, President, will be presenting on Wednesday January 14, 2009 at 1:25 PM PT.
A live audio webcast of Martek's presentation can be accessed at: http://investor.shareholder.com/icr/eventdetail.cfm?eventid=64032
Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.
Contact: Kyle Stults Investor Relations (410) 740-0081
SOURCE Martek Biosciences Corporation